What is the differential diagnosis for a patient with bilateral pleural effusions and cytologic findings of large atypical cells in the pleural fluid?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 18, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Differential Diagnosis of Malignant Pleural Effusion with Atypical Cells

The cytologic findings of large atypical cells arranged in clusters with papillary groups, high nuclear-to-cytoplasmic ratios, pleomorphism, prominent nucleoli, and cytoplasmic vacuolation are highly suspicious for metastatic adenocarcinoma, which represents the most common cause of malignant pleural effusions, though mesothelioma, lymphoma, and other malignancies must also be considered in the differential.

Primary Differential Considerations

Metastatic Adenocarcinoma (Most Likely)

  • Adenocarcinoma has the highest diagnostic yield on pleural fluid cytology and is the most common cause of malignant pleural effusions 1.
  • The cytologic features described—papillary groups, cytoplasmic vacuolation, and high nuclear-to-cytoplasmic ratios—are classic for adenocarcinoma 1.
  • In this obese 66-year-old woman with abdominal bloating, primary sites to consider include:
    • Ovarian adenocarcinoma: Papillary architecture and bilateral effusions are characteristic; abdominal bloating suggests possible peritoneal involvement 1.
    • Breast adenocarcinoma: Common in women this age 2.
    • Lung adenocarcinoma: Most frequent primary site overall for malignant pleural effusions 1.
    • Gastrointestinal adenocarcinoma: Including gastric, pancreatic, or colorectal primaries 1.

Malignant Mesothelioma

  • Mesothelioma presents with large atypical mesothelial cells that can mimic adenocarcinoma 1.
  • However, cytology has poor sensitivity for mesothelioma (16%-30%), making this diagnosis less likely on cytology alone 1, 3.
  • Bilateral effusions are common in mesothelioma 1.
  • Critical caveat: The International Mesothelioma Interest Group recommends that mesothelioma diagnosis should always be based on biopsy rather than cytology alone 3.

Hematologic Malignancies

  • Lymphoma can present with large atypical cells in pleural fluid, though typically these are discohesive rather than in clusters 4.
  • Flow cytometry is a useful adjunct for differentiating lymphoma 1, 5.
  • Less common but documented causes include acute lymphoid leukemia and multiple myeloma 4.

Other Malignancies

  • Squamous cell carcinoma and small cell carcinoma are less common causes and typically have lower cytologic diagnostic yields than adenocarcinoma 1.
  • Rare metastases from sarcomas (Ewing's sarcoma, malignant fibrous histiocytoma) have been reported but are uncommon 4.

Diagnostic Approach

Immediate Next Steps

  • Immunocytochemistry is essential to distinguish between adenocarcinoma and mesothelioma and to identify the primary site 1.
  • Key immunohistochemical panels include 1:
    • For adenocarcinoma: CEA, B72.3, BerEP4, MOC-31
    • For mesothelioma: Calretinin, CK5/6, D2-40, WT-1
    • Organ-specific markers: TTF-1/Napsin A (lung), PAX-8/WT1 (gynecologic), Mammaglobin/ER/PR/GATA3 (breast), CDX-2/CK20 (GI)

If Initial Cytology is Non-Diagnostic

  • Submit a second pleural fluid specimen, as this yields an additional 25%-28% diagnostic rate 1.
  • Both cell blocks and smears should be prepared to maximize diagnostic yield 1.
  • Submit 75-150 mL of fluid when using combined direct smear and cell block preparations 1.

When Pleural Biopsy is Required

  • If cytology remains negative but clinical suspicion is high, proceed to pleural biopsy (image-guided or thoracoscopic), which has >92% sensitivity for malignancy 3, 5.
  • Pleural biopsy is particularly important for:
    • Suspected mesothelioma (cytology sensitivity only 16%-30%) 1, 3.
    • Obtaining sufficient tissue for molecular profiling to guide targeted therapies 3, 5.
    • Providing prognostic information 3.

Clinical Context Integration

Imaging Correlation

  • Obtain contrast-enhanced CT chest and abdomen to identify the primary tumor and assess for features suggestive of malignancy 1:
    • Circumferential pleural thickening (specificity 100%)
    • Nodular pleural thickening (specificity 94%)
    • Parietal pleural thickening >1 cm (specificity 94%)
    • Mediastinal pleural involvement (specificity 88%)

Additional Workup Based on Primary Site

  • Given abdominal bloating in this woman, pelvic ultrasound or CT abdomen/pelvis should be obtained to evaluate for ovarian or other gynecologic malignancy 1.
  • CA-125 may be elevated in ovarian cancer with pleural involvement.
  • Consider mammography if breast primary is suspected 1.

Common Pitfalls to Avoid

  • Do not rely on cytology alone for mesothelioma diagnosis—tissue biopsy is required 3.
  • Do not submit only conventional smears—cell block preparation significantly increases diagnostic yield 1, 6.
  • Do not assume tuberculosis is excluded if mesothelial cells are present (12% of tuberculous effusions have >5% mesothelial cells) 7.
  • Do not perform more than two thoracenteses for cytology—the third specimen adds only 5% diagnostic yield 1.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Diagnostic Approach to Mitotic Cells in Pleural Fluid

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Cytopathological spectrum of unusual malignant pleural effusions at a tertiary care centre in north India.

Cytopathology : official journal of the British Society for Clinical Cytology, 2007

Guideline

Diagnostic Approach to Lymphoid-Rich Pleural Effusion

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.